Back
Viking Therapeutics, Inc. 10K Form
Sell
38
VKTX
Viking Therapeutics, Inc.
Last Price:
$29.00
Seasonality Move:
8.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VKTX News And Ratings
See the #1 stock for the next 7 days that we like better than VKTX
VKTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-85.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.57 |
| Price / Book: | 5.39 |
Profitability
| EPS (TTM): | -3.18310 |
|---|---|
| Net Income (TTM): | $-359.6M |
| Gross Margin: | $-346K |
| Return on Equity: | -46.41% |
| Return on Assets: | -44.31% |
Viking Therapeutics, Inc. Earnings Forecast
Key Viking Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 4 years.
Viking Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VKTX |
| CUSIP: | 92686J |
| Website: | vikingtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.33 |
| Quick Ratio: | 9.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VKTX Technical Analysis vs Fundamental Analysis
Sell
38
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy or a Sell?
-
Viking Therapeutics, Inc. stock is rated a SellThe current Viking Therapeutics, Inc. [VKTX] share price is $30.49. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.